{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T21:56:50Z","timestamp":1791323810924,"version":"4.3.1"},"reference-count":121,"publisher":"Informa UK Limited","issue":"12","content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Opinion on Therapeutic Patents"],"published-print":{"date-parts":[[2020,12,1]]},"DOI":"10.1080\/13543776.2020.1839415","type":"journal-article","created":{"date-parts":[[2020,10,20]],"date-time":"2020-10-20T11:21:55Z","timestamp":1603192915000},"page":"983-1000","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":30,"title":["Micro\/nanosystems and biomaterials for controlled delivery of antimicrobial and anti-biofilm agents"],"prefix":"10.1080","volume":"30","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3160-9586","authenticated-orcid":false,"given":"Annalisa","family":"Bianchera","sequence":"first","affiliation":[{"name":"Food and Drug Department, University of Parma, Parma, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4472-4823","authenticated-orcid":false,"given":"Francesca","family":"Buttini","sequence":"additional","affiliation":[{"name":"Food and Drug Department, University of Parma, Parma, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3857-7476","authenticated-orcid":false,"given":"Ruggero","family":"Bettini","sequence":"additional","affiliation":[{"name":"Food and Drug Department, University of Parma, Parma, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2020,11,3]]},"reference":[{"key":"cit0001","doi-asserted-by":"publisher","DOI":"10.1155\/2012\/528521"},{"key":"cit0002","doi-asserted-by":"publisher","DOI":"10.1038\/nrmicro.2016.94"},{"key":"cit0003","doi-asserted-by":"publisher","DOI":"10.2217\/fmb.12.76"},{"key":"cit0004","doi-asserted-by":"publisher","DOI":"10.1186\/s13756-019-0533-3"},{"key":"cit0005","doi-asserted-by":"publisher","DOI":"10.1007\/s10096-015-2323-z"},{"key":"cit0006","doi-asserted-by":"publisher","DOI":"10.1016\/j.rmed.2016.06.015"},{"key":"cit0007","doi-asserted-by":"publisher","DOI":"10.1016\/j.addr.2014.08.013"},{"key":"cit0008","doi-asserted-by":"publisher","DOI":"10.1089\/jamp.2017.1415"},{"key":"cit0009","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.01102-2015"},{"key":"cit0010","first-page":"210","volume":"6","author":"Johnson MM","year":"2014","journal-title":"J Thorac Dis"},{"key":"cit0011","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2013.06.049"},{"key":"cit0012","doi-asserted-by":"publisher","DOI":"10.1038\/nrd2153"},{"key":"cit0013","first-page":"S1","volume":"21","author":"H\u00f8iby N","year":"2015","journal-title":"Clin Microbiol Infect Official Publ European Soc Clin Microbiol Infect Dis"},{"key":"cit0014","doi-asserted-by":"publisher","DOI":"10.1038\/nature02122"},{"key":"cit0015","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcf.2015.02.005"},{"key":"cit0016","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejpb.2015.01.012"},{"key":"cit0017","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2018.06.006"},{"key":"cit0018","unstructured":"Tarara TE, Weers JG, Eldon MA, et al. inventors. Novartis AG, assignee. Formulation for pulmonary administration of antifungal agents, and associated methods of manufacture and use. US8404217B2, March 2013"},{"key":"cit0019","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcf.2010.10.003"},{"key":"cit0020","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2016.02.005"},{"key":"cit0021","unstructured":"Flynn RA, Goldman MH, Lovely JR, inventors. Pharmax Limited, assignee. Micronised pharmaceutical compositions. WO2000016745, March, 30, 2000."},{"key":"cit0022","unstructured":"Montgomery AB, inventor. Corus Pharma Inc, assignee. Inhalable aztreonam aerosol for treatment and prevention of pulmonary bacterial infections. US7208141B2, April 24, 2007."},{"key":"cit0023","doi-asserted-by":"publisher","DOI":"10.1378\/chest.08-1421"},{"key":"cit0024","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcf.2013.08.011"},{"key":"cit0025","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dks296"},{"key":"cit0026","doi-asserted-by":"publisher","DOI":"10.1111\/j.1574-695X.2010.00755.x"},{"key":"cit0027","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01744-10"},{"key":"cit0028","unstructured":"https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02157922"},{"key":"cit0029","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00525-12"},{"key":"cit0030","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2016.09.034"},{"key":"cit0031","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2018.01.022"},{"key":"cit0032","unstructured":"Smyth H, Bahamondez-Canas T, Tewes F, et al. inventors. Board of regentes of the university of Texas system, assignee. Antibiofilm formulations and use thereof. WO2019104213A1, May 31, 2019."},{"key":"cit0033","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2020.106022"},{"key":"cit0034","doi-asserted-by":"publisher","DOI":"10.1111\/j.1524-475X.2012.00836.x"},{"key":"cit0035","doi-asserted-by":"publisher","DOI":"10.1111\/j.1524-475X.2007.00283.x"},{"key":"cit0036","doi-asserted-by":"publisher","DOI":"10.3390\/microorganisms5010009"},{"key":"cit0037","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2017.00274"},{"key":"cit0038","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0183271"},{"key":"cit0039","doi-asserted-by":"publisher","DOI":"10.1002\/9781119433316.ch15"},{"key":"cit0040","unstructured":"World Union of Wound Healing Societies (WUWHS), Florence Congress, Position Document. Management of biofilm. Wounds International 2016"},{"key":"cit0041","doi-asserted-by":"publisher","DOI":"10.1517\/13543776.2010.505923"},{"key":"cit0042","doi-asserted-by":"publisher","DOI":"10.1016\/j.tim.2019.07.004"},{"key":"cit0043","doi-asserted-by":"publisher","DOI":"10.1039\/C4CC07737G"},{"key":"cit0044","doi-asserted-by":"publisher","DOI":"10.1039\/C7CS00807D"},{"key":"cit0045","doi-asserted-by":"publisher","DOI":"10.1021\/es103450g"},{"key":"cit0046","doi-asserted-by":"publisher","DOI":"10.1016\/j.colsurfb.2018.09.018"},{"key":"cit0047","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0131806"},{"key":"cit0048","doi-asserted-by":"publisher","DOI":"10.1016\/j.addr.2014.08.004"},{"key":"cit0049","doi-asserted-by":"publisher","DOI":"10.1111\/cpr.12616"},{"key":"cit0050","first-page":"18877","volume":"6","author":"Mu H","year":"2016","journal-title":"Biofilm Intracell Bact Sci Rep"},{"key":"cit0051","doi-asserted-by":"publisher","DOI":"10.1016\/j.colsurfb.2018.12.035"},{"key":"cit0052","doi-asserted-by":"publisher","DOI":"10.1128\/AEM.02941-10"},{"key":"cit0053","doi-asserted-by":"publisher","DOI":"10.1021\/bm302003m"},{"key":"cit0054","doi-asserted-by":"publisher","DOI":"10.3390\/ma10060659"},{"key":"cit0055","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2015.04.028"},{"key":"cit0056","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcis.2018.05.014"},{"key":"cit0057","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2018.06.017"},{"key":"cit0058","doi-asserted-by":"publisher","DOI":"10.1021\/acsami.9b21815"},{"key":"cit0059","doi-asserted-by":"publisher","DOI":"10.1101\/337436"},{"key":"cit0060","doi-asserted-by":"publisher","DOI":"10.1016\/j.colsurfb.2015.08.027"},{"key":"cit0061","doi-asserted-by":"publisher","DOI":"10.1016\/j.colsurfa.2011.08.035"},{"key":"cit0062","doi-asserted-by":"publisher","DOI":"10.1164\/ajrccm.162.5.9909009"},{"key":"cit0063","doi-asserted-by":"publisher","DOI":"10.1080\/10611860600834375"},{"key":"cit0064","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejpb.2018.07.025"},{"key":"cit0065","doi-asserted-by":"publisher","DOI":"10.1007\/s10439-012-0626-0"},{"key":"cit0066","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2006.08.034"},{"key":"cit0067","doi-asserted-by":"publisher","DOI":"10.1016\/S0927-7757(01)00481-2"},{"key":"cit0068","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2019.03.051"},{"key":"cit0069","doi-asserted-by":"publisher","DOI":"10.1021\/acsami.9b19644"},{"key":"cit0070","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcis.2019.08.006"},{"key":"cit0071","doi-asserted-by":"publisher","DOI":"10.1021\/acs.molpharmaceut.0c00346"},{"key":"cit0072","doi-asserted-by":"crossref","unstructured":"Kim MH. Nanoparticle-based therapies for wound biofilm infection: opportunities and challenges. IEEE Trans Nanobioscience. 2016;15(3):294\u2013304.","DOI":"10.1109\/TNB.2016.2527600"},{"key":"cit0073","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2020.01705"},{"key":"cit0074","unstructured":"Yee A, Rosenzweig L, Disckson MN, et al. inventors. The Regents of the University of California, assignee. Novel anti-bacterial anti-fungal nanopillared surface US20190076573A1 March 14, 2019."},{"key":"cit0075","unstructured":"Klein J, Lin W, Goldberg R, inventors. Yeda Research and Development Co. assignee. Lipid analogs and liposomes comprising same. WO2017109784, December 12, 2016."},{"key":"cit0076","unstructured":"Boluk Y, Liu Y, Sun X, inventors. The Governors of the University of Alberta, assignee. Nanocrystalline cellulose hydrogels for inhibition of bacterial adhesion. US2016346436A1,December 1, 2016."},{"key":"cit0077","unstructured":"Miller L, Mao HQ, Ashbaugh A et al. inventors. The Johns Hopkins University, assignee. Compositions and methods for preparation of composite polymer films on non-conducting substrates, including bandages, and their use for treating wounds. WO2020037218A1, February 20, 2020."},{"key":"cit0078","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1613722113"},{"key":"cit0079","unstructured":"Dolan RM, Lehman SM, Garcia AJ, inventors. The Government of the United States of America-Georgia Tech research corporation, applicant. Controlled covalent attachment of bioactive bacteriophages for regulating biofilm development. WO2013048604A2, April 4, 2013."},{"key":"cit0080","unstructured":"Sauer K, Doiron AL, inventors. The Research Foundation for the State University of New York, applicant. Compositions and methods for disrupting biofilm formation and maintenance. US20190365868A1, December 12, 2019."},{"key":"cit0081","doi-asserted-by":"publisher","DOI":"10.1016\/j.colsurfb.2019.110512"},{"key":"cit0082","unstructured":"Iyer AK, Sau S, Rybak M, et al. inventors. Wayne state University, applicant. Drug delivery systems for treatment of infections. WO2019133916A1, July 4, 2019."},{"key":"cit0083","doi-asserted-by":"publisher","DOI":"10.3390\/ma11071245"},{"key":"cit0084","unstructured":"Loo SCJ, Baek J, Tan CH, inventors. Nanyang technological university, National University of Singapore, applicants. Lipid-polymer hybrid nanoparticles. WO2019135715A1, July 11, 2019."},{"key":"cit0085","unstructured":"Schoenfisch MH, Reighard K, inventors. The University of North Carolina at Chapel Hill, assignee. Compounds, compositions and methods for inhibiting a pathogen and\/or modifying mucus. US2020085858A1, March 9, 2020."},{"key":"cit0086","doi-asserted-by":"publisher","DOI":"10.1128\/JB.00779-06"},{"key":"cit0087","unstructured":"Boyer CAJM, Barraud N, Duong HTT, inventors. Newsouth innovations PTY limited, assignee, Anti-biofilm polymer. WO2015139079A1, September 24, 2015."},{"key":"cit0088","doi-asserted-by":"publisher","DOI":"10.4161\/viru.20328"},{"key":"cit0089","unstructured":"Handa H, Pant J, inventors. University of Georgia research foundation assignee. Antimicrobial compositions with wound healing properties. WO2019236825A1, December 12, 2019."},{"key":"cit0090","unstructured":"Meledandri CJ, Schwass DR, Cotton CG, et al. inventorse. Otago Innovation Limited, assignee. Antimicrobial gel containing silver nanoparticles. WO2017061878A1, April 13, 2017."},{"key":"cit0091","unstructured":"Seo DK, Haydel S Antimicrobial geopolymer compositions. WO2018013830A1, January 18, 2018."},{"key":"cit0092","unstructured":"Zale SE, inventor. Pfizer Inc. assignee. Therapeutic nanoparticles comprising an antibiotic and methods of making and using same. WO2017089942A1, June 1, 2017."},{"key":"cit0093","unstructured":"Hilliard C, Cast WR Methods to prevent tissue colonization of pathogens and for treatment of biofilms on animal tissues. WO2016187391A1, November 24, 2016."},{"key":"cit0094","unstructured":"Hilliard C, William R. Cast. Product and delivery system for application of antimicrobial treatment designed to inhibit pathogens from entering or leaving a respiratory system and to remove pathogens from wounds, ears or other body cavities and methods of use. US20150328240A1, November 19, 2015."},{"key":"cit0095","unstructured":"Bakaletz LO, Goodman SD, inventors. Research institute at National Children\u2019s hospital, applicant. Peptides and antibodies for the removal of biofilms. WO2017023863A1, February 9, 2017."},{"key":"cit0096","unstructured":"Rhinotopic LLC. Bioadhesive and biodegradable and formulations that provide sustained release of antimicrobials, bacteriophages and anti-inflammatory medications for inactivation of biofilms and the treatment of rhinosinusitis and other infections. US2016022595A1, January 28, 2016."},{"key":"cit0097","unstructured":"Weers J, inventor. Insmed Inc. assignee. Lipid-based compositions of antiinfectives for treating pulmonary infections and methods of use thereof. US8226975B2, July 24, 2012."},{"key":"cit0098","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcf.2015.02.005"},{"key":"cit0099","unstructured":"Cipolla DC, Blanchard J inventors. Aradigm corporation. Dual action, inhaled formulations providing both an immediate and sustained release profile. US20120282328A1, November 8, 2012."},{"key":"cit0100","first-page":"195:A7604","author":"Haworth C","year":"2017","journal-title":"Am J Resp Crit Care Med"},{"key":"cit0101","unstructured":"https:\/\/www.ema.europa.eu\/en\/documents\/withdrawal-letter\/withdrawal-letter-linhaliq_en.pdf"},{"key":"cit0102","first-page":"6","volume":"8","author":"Cipolla D","year":"2016","journal-title":"Pharm"},{"key":"cit0103","unstructured":"Ambati S, Meagher RB, Lewis Z, et al. inventors. University of Georgia Research foundation assignee. Targeted nanoparticles and their uses related to fungal infections. WO2020146514A1, July 16, 2020."},{"key":"cit0104","unstructured":"Millenbaugh N, inventor. The United States of America Represented by the Secretary of Navy, assignee. Method of treating multi-drug resistance biofilm using targeted laser and antibiotics. US20190255349A1, August 22, 2019."},{"key":"cit0105","unstructured":"Braeckmans K, Coenye T, Demeester J, et al. inventors. Universiteit Gent, assignee. Disruption or alteration of microbiological films. WO2017009039A1, January 19, 2017."},{"key":"cit0106","unstructured":"Sawyer A, Stockel RF, inventors. Nevada Naturals Inc. assignee. Biofilm penetrating compositions and methods. WO2018201119A1, November 1, 2018."},{"key":"cit0107","unstructured":"Thomas ND, Richter K, Prestidge CA, inventors. University of South Australia, assignee. Antimicrobial compositions and methods of use. WO2019036770A1, February 28, 2019."},{"key":"cit0108","unstructured":"Luukko K, Nuopponen M, Curzio N, et al. inventors. UPM-KYMMENE Corporation, assignee. A medical product comprising bioactive molecule immobilized to nanofibrillar cellulose and method for preparing thereof. WO2019166606A1, September 6, 2019."},{"key":"cit0109","unstructured":"Mohapatra SS, Limayem A Compositions for treating drug resistant bacteria and biofilm. US20190134086, A1 May 9, 2019."},{"key":"cit0110","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2019.05.003"},{"key":"cit0111","unstructured":"Theivendran S, Kubinec JJ, Smith TR Functional nanoparticle composite comprising chitosan. US2016369065A1, December 22, 2016."},{"key":"cit0112","unstructured":"Benoit D, Koo H, inventors. University of Rochester, assignee. Nanoparticles for controlled release of anti-biofilm agents and methods of use. WO2018026764A1, February 8, 2018."},{"key":"cit0113","unstructured":"Mohapatra A, Harris MA, Morshed BI, et al. inventors. The University of Memphis research foundation, assignee. Microbead compositions an methods for delivering an agent. WO2018064150A1, April 5, 2018."},{"key":"cit0114","unstructured":"Yeoman RR, Winchurch RA, inventors. NanoDERM sciences Inc, assignee. Targeted nanoparticles. US2018028684A1, February 1, 2018."},{"key":"cit0115","unstructured":"Abbott NL, McAnulty JF Methods and compositions for wound healing. WO2020037211A1, February 20, 2020."},{"key":"cit0116","unstructured":"Kaplan DL, Panilaitis B, Pritchard EM et al. Silk fibroin systems for antibiotic delivery. US2012052124A1, March 1, 2012."},{"key":"cit0117","doi-asserted-by":"publisher","DOI":"10.1002\/adfm.201201636"},{"key":"cit0118","unstructured":"Mahmoudi M. Nanofibrous scaffolds to heal chronic skin wounds. WO2019222511A1, November 21, 2019."},{"key":"cit0119","unstructured":"Rotello VM, Landis RF, inventors.The University of Massachussetts, assignee. Crosslinked particles, composition comprising the crosslinked particles, method for the manufacture thereof, and method of treating an infection. WO2019118444A1, June 20, 2019."},{"key":"cit0120","unstructured":"Duncan B, Li X, Rotello VM, inventors. The University of Massachussetts, assignee. Nanoparticle-stabilized microcapsules, dispersions comprising nanoparticle-stabilized microcapsules, and method for the treatment of bacterial biofilms. US10272126B2, April 30, 2019."},{"key":"cit0121","doi-asserted-by":"publisher","DOI":"10.1080\/17425247.2020.1789585"}],"container-title":["Expert Opinion on Therapeutic Patents"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/13543776.2020.1839415","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,8]],"date-time":"2021-05-08T14:57:14Z","timestamp":1620485834000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/13543776.2020.1839415"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,3]]},"references-count":121,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2020,12,1]]}},"alternative-id":["10.1080\/13543776.2020.1839415"],"URL":"https:\/\/doi.org\/10.1080\/13543776.2020.1839415","relation":{},"ISSN":["1354-3776","1744-7674"],"issn-type":[{"value":"1354-3776","type":"print"},{"value":"1744-7674","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,11,3]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ietp20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ietp20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2020-09-03","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-10-16","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-11-03","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}